Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 712737 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Search Results

Your Search for 'Understanding Genomics and Global Health Impacts' returned 38 results - Page 1 of 2

 FEATURED RESULTS
Cytogenetics - Technologies, Markets and Companies

Personalized Medicine - Scientific and Commercial Aspects

Gene Therapy - Technologies, Markets and Companies

Cell Therapy - Technologies, Markets and Companies

RNAi - Technologies, Markets and Companies


  Sort by   
  Sorted by Rank Top-Bottom

Innovations in Combating Infectious Diseases: Opportunities in Therapeutics and Diagnostics through Application of Proteomics, Genomics, Nanotechnology, and Novel Sources of Lead Generation  
Business Insights, June 2010, Pages: 250
diseases - How proteomics is being used to identify novel targets for drug discovery and vaccine development in infectious diseases - The impact of genomics on the search for novel targets for infectious


Personalized Medicine - Scientific and Commercial Aspects  
Jain PharmaBiotech, Feb 2012, Pages: 780
of personalized medicine Global scope of personalized medicine Personalized medicine in the developed countries Personalized medicine in the US Personalized medicine in the EU UK National Health Service


Personalized Medicine 2010  
Arrowhead Publishers, May 2010, Pages: 261
DIAGNOSTICS 5.2.1 Roche/Affymetrix’s AmpliChip Cytochrome P450 Genotyping Test (AmpliChip CYP450) 5.2.3 Agendia’s MammaPrint 5.2.4 Genomic Health’s OncoType DX Test 5.2.5 Genentech/Roche/Dako’s HercepTest 5


Advancing Molecular Diagnostics to Personalize Cancer Therapy  
Business Insights, June 2011, Pages: 187
Introduction Trends in cancer diagnostics Market developments Market analysis About the author Disclaimer Introduction Summary Perspective Growing global incidence of cancer The impact of unhealthy


Genomics, Proteomics and Metabolomics in Diagnostics: Market Landscape, Innovative Technologies and Future Outlook  
Business Insights, March 2010, Pages: 185
market in genomics, proteomics and metabolomics on the basis of: - Technologies - Applications - Strategic issues and innovations Key features of this report - Measures the global diagnostics market with respect


Molecular Diagnostics in Cancer Testing  
TriMark Publications, July 2011, Pages: 214
.4 Objectives 1.5 Methodology 1.6 Executive Summary 2. Introduction to Molecular Diagnostics 2.1 Opening-up of Opportunities in Molecular Diagnostics 2.2 Impact of the Human Genome Project on Molecular


Genetic Engineering - Global Outlook  
Global Industry Analysts, Inc., Oct 2009, Pages: 63
The global outlook series on Genetic Engineering provides a collection of market briefs and concise summaries of research findings. The report offers a bird’s eye view of the industry, highlights


Dealmaking and Business Strategies in the Age of Personalized Medicine  
Decision Resources, Inc., March 2009, Pages: 31
- Genome Health - Harvard Pilgrim Health Care - Healthcare Leadership Council - HP - IBM - Indiana University - Kaiser - LabCorp - Mayo Clinic - McKesson - Medco Health Solutions - Merck & Co. - Novartis


New technologies in Aquaculture: Improving Production Efficiency, Quality and Environmental Management  
Woodhead Publishing Ltd, July 2009, Pages: 1232
- Global increase of harmful algal bloom (HAB) - Impact of harmful algal bloom species on shellfisheries industries - Prevention of harmful algal bloom threat - Conclusions - Acknowledgements


Innovations in Oncology Diagnostics: Technological Advances, Growth Opportunities and Future Market Outlook  
Business Insights, Oct 2009, Pages: 141
Despite public policy measures to prevent cancer, such as tobacco control and vaccination against HPV, cancer is sure to remain a significant public health problem throughout the 21st century


Biomarker and Diagnostic Opportunities Associated with Targeted Cancer Therapies  
Decision Resources, Inc., Dec 2009, Pages: 34
Are the Oncologists Saying? Impact on Clinical Practice Use of Diagnostic Imaging Genetic Biomarkers in Cancer Trials Indication-Specific Trends Phase of Development Cancer Screening on the Global Radar


Molecular Diagnostics Markets  
TriMark Publications, July 2011, Pages: 335
to Molecular Diagnostics and PCR Technology 2.1 Introduction to Genomics and Its Opportunity 2.2 Impact of the Human Genome Project on Molecular Diagnostics 2.3 Key Considerations for Molecular Diagnostics 2


DNA Probes-Based Diagnostics - Global Strategic Business Report  
Global Industry Analysts, Inc., Jan 2011, Pages: 448
18 Molecular Diagnostics: Marking the Convergence of Numerous Technologies 18 Impact of the Human Genome Project


How to Get Ahead with Pharmacogenomics  
Decision Resources, Inc., March 2008, Pages: 42
Healthcare - Genedata - GeneGo - Genentech - General Electric - General Electric Global Research - Genmab - Genomic Health - Genzyme Genetics - GlaxoSmithKline - GVK BioSciences - ICOS - Illumina - Im


Companion Biomarkers in Drug Development  
TriMark Publications, April 2009, Pages: 320
Regulatory Responsibilities 190 9.9 Role of National Institute of Standards and Technology in Validation of Biomarkers 191 9.10 Biomarkers and FDA's Voluntary Genomic Data Submission 191 9.11 Federal Health


Impact of Pharmacogenomics on Public Healthcare Policy: Educating Patients, Payors and Healthcare Providers  
Business Insights, March 2008, Pages: 171
to PGx 85 Clinical Data 86 Dako 88 Diaceutics 89 Genomic Health 91 Genzyme Genetics 93 Monogram Biosciences 95 Conclusions- Diagnostic PGx strategies 97 Interactions between stakeholders 98 Consortia 100


Biomarkers - Advanced Technologies and Global Market (2009-2014)  
Markets and Markets, Sep 2009, Pages: 256
globally 6.13. Drug Development & Discovery 6.13.1. Drug Targets 6.13.1.1. Target Validation 6.13.1.1.1. Target Discovery 6.13.1.2. Target Discovery Using Functional Genomics 6.13.2. ADME-TOX profiling


Biomarker Technology Platforms for Cancer Diagnoses and Therapies  
TriMark Publications, Sep 2011, Pages: 343
.4.1.3 Questions About Testing 5.4.1.4 HER2 Tumor Status 5.5 Herceptin Treatment 5.6 Tumor Assays for Adjuvant Chemotherapy 5.7 Use of Genomics to Understand Breast Cancer 5.8 Genetic Analysis Solution 5


Pharmacogenomics for Clinical Use and in Drug Development  
TriMark Publications, June 2009, Pages: 244
.1.2 Technologies for Pharmacogenomic Diagnostic Tools 19 2.1.3 Drug and Diagnostic Combinations 22 2.1.4 Economic Impact of Healthcare Costs 23 2.2 Genetic Variation among Individuals 33 2.2.1 Population Genomics 33


Biomarkers in Late Stage Clinical Trials: Applications, Opportunities and Activities of Leading Players  
Business Insights, April 2010, Pages: 178
- Provides patent analysis with respect to competitors and geography. Scope of this report - Understand and evaluate the growth potential of emerging technologies. - Understand biomarker activity


Results:  First -   Prev -   1 -   2 -   Next -   Last


For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds